Global Influenza Vaccination Market Insights, Forecast to 2025

Publisher Name :
Date: 14-May-2019
No. of pages: 118
Inquire Before Buying

Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused

Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.

The global Influenza Vaccination market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Influenza Vaccination market based on company, product type, end user and key regions.

This report studies the global market size of Influenza Vaccination in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Influenza Vaccination in these regions.

This research report categorizes the global Influenza Vaccination market by top players/brands, region, type and end user. This report also studies the global Influenza Vaccination market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Abbott (U.S.)

- AstraZeneca (Europe)

- BioCryst Pharmaceuticals, Inc. (U.S.)

- Novartis AG (Europe)

- DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)

- GlaxoSmithKline plc. (Europe)

- Hualan Biological Engineering Inc (Asia Pacific)

- Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

- F. Hoffmann-La Roche Ltd (Europe)

- Sanofi (Europe)

Market size by Product

- by Technology

- - Egg Based

- - Cell Culture

- - Recombinant

- by Vaccines

- - Fluzone

- - Flumist

- - Fluvirin

- - Fluvax

Market size by End User

- Hospitals

- Research Organizations

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Influenza Vaccination market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Influenza Vaccination market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Influenza Vaccination companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Influenza Vaccination submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Influenza Vaccination are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Influenza Vaccination market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Influenza Vaccination Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Influenza Vaccination Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Influenza Vaccination Market Size Growth Rate by Product
1.4.2 Egg Based
1.4.3 Cell Culture
1.4.4 Recombinant
1.5 Market by End User
1.5.1 Global Influenza Vaccination Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccination Market Size
2.1.1 Global Influenza Vaccination Revenue 2014-2025
2.1.2 Global Influenza Vaccination Sales 2014-2025
2.2 Influenza Vaccination Growth Rate by Regions
2.2.1 Global Influenza Vaccination Sales by Regions
2.2.2 Global Influenza Vaccination Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Influenza Vaccination Sales by Manufacturers
3.1.1 Influenza Vaccination Sales by Manufacturers
3.1.2 Influenza Vaccination Sales Market Share by Manufacturers
3.1.3 Global Influenza Vaccination Market Concentration Ratio (CR5 and HHI)
3.2 Influenza Vaccination Revenue by Manufacturers
3.2.1 Influenza Vaccination Revenue by Manufacturers (2014-2019)
3.2.2 Influenza Vaccination Revenue Share by Manufacturers (2014-2019)
3.3 Influenza Vaccination Price by Manufacturers
3.4 Influenza Vaccination Manufacturing Base Distribution, Product Types
3.4.1 Influenza Vaccination Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Vaccination Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Vaccination Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Influenza Vaccination Sales by Product
4.2 Global Influenza Vaccination Revenue by Product
4.3 Influenza Vaccination Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Influenza Vaccination Breakdown Data by End User
6 North America
6.1 North America Influenza Vaccination by Countries
6.1.1 North America Influenza Vaccination Sales by Countries
6.1.2 North America Influenza Vaccination Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Influenza Vaccination by Product
6.3 North America Influenza Vaccination by End User
7 Europe
7.1 Europe Influenza Vaccination by Countries
7.1.1 Europe Influenza Vaccination Sales by Countries
7.1.2 Europe Influenza Vaccination Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Influenza Vaccination by Product
7.3 Europe Influenza Vaccination by End User
8 Asia Pacific
8.1 Asia Pacific Influenza Vaccination by Countries
8.1.1 Asia Pacific Influenza Vaccination Sales by Countries
8.1.2 Asia Pacific Influenza Vaccination Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Influenza Vaccination by Product
8.3 Asia Pacific Influenza Vaccination by End User
9 Central & South America
9.1 Central & South America Influenza Vaccination by Countries
9.1.1 Central & South America Influenza Vaccination Sales by Countries
9.1.2 Central & South America Influenza Vaccination Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Influenza Vaccination by Product
9.3 Central & South America Influenza Vaccination by End User
10 Middle East and Africa
10.1 Middle East and Africa Influenza Vaccination by Countries
10.1.1 Middle East and Africa Influenza Vaccination Sales by Countries
10.1.2 Middle East and Africa Influenza Vaccination Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Influenza Vaccination by Product
10.3 Middle East and Africa Influenza Vaccination by End User
11 Company Profiles
11.1 Abbott (U.S.)
11.1.1 Abbott (U.S.) Company Details
11.1.2 Company Business Overview
11.1.3 Abbott (U.S.) Influenza Vaccination Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbott (U.S.) Influenza Vaccination Products Offered
11.1.5 Abbott (U.S.) Recent Development
11.2 AstraZeneca (Europe)
11.2.1 AstraZeneca (Europe) Company Details
11.2.2 Company Business Overview
11.2.3 AstraZeneca (Europe) Influenza Vaccination Sales, Revenue and Gross Margin (2014-2019)
11.2.4 AstraZeneca (Europe) Influenza Vaccination Products Offered
11.2.5 AstraZeneca (Europe) Recent Development
11.3 BioCryst Pharmaceuticals, Inc. (U.S.)
11.3.1 BioCryst Pharmaceuticals, Inc. (U.S.) Company Details
11.3.2 Company Business Overview
11.3.3 BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Sales, Revenue and Gross Margin (2014-2019)
11.3.4 BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Products Offered
11.3.5 BioCryst Pharmaceuticals, Inc. (U.S.) Recent Development
11.4 Novartis AG (Europe)
11.4.1 Novartis AG (Europe) Company Details
11.4.2 Company Business Overview
11.4.3 Novartis AG (Europe) Influenza Vaccination Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis AG (Europe) Influenza Vaccination Products Offered
11.4.5 Novartis AG (Europe) Recent Development
11.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
11.5.1 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Company Details
11.5.2 Company Business Overview
11.5.3 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Sales, Revenue and Gross Margin (2014-2019)
11.5.4 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Products Offered
11.5.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Recent Development
11.6 GlaxoSmithKline plc. (Europe)
11.6.1 GlaxoSmithKline plc. (Europe) Company Details
11.6.2 Company Business Overview
11.6.3 GlaxoSmithKline plc. (Europe) Influenza Vaccination Sales, Revenue and Gross Margin (2014-2019)
11.6.4 GlaxoSmithKline plc. (Europe) Influenza Vaccination Products Offered
11.6.5 GlaxoSmithKline plc. (Europe) Recent Development
11.7 Hualan Biological Engineering Inc (Asia Pacific)
11.7.1 Hualan Biological Engineering Inc (Asia Pacific) Company Details
11.7.2 Company Business Overview
11.7.3 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Products Offered
11.7.5 Hualan Biological Engineering Inc (Asia Pacific) Recent Development
11.8 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
11.8.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Details
11.8.2 Company Business Overview
11.8.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Products Offered
11.8.5 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Recent Development
11.9 F. Hoffmann-La Roche Ltd (Europe)
11.9.1 F. Hoffmann-La Roche Ltd (Europe) Company Details
11.9.2 Company Business Overview
11.9.3 F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Sales, Revenue and Gross Margin (2014-2019)
11.9.4 F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Products Offered
11.9.5 F. Hoffmann-La Roche Ltd (Europe) Recent Development
11.10 Sanofi (Europe)
11.10.1 Sanofi (Europe) Company Details
11.10.2 Company Business Overview
11.10.3 Sanofi (Europe) Influenza Vaccination Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Sanofi (Europe) Influenza Vaccination Products Offered
11.10.5 Sanofi (Europe) Recent Development
12 Future Forecast
12.1 Influenza Vaccination Market Forecast by Regions
12.1.1 Global Influenza Vaccination Sales Forecast by Regions 2019-2025
12.1.2 Global Influenza Vaccination Revenue Forecast by Regions 2019-2025
12.2 Influenza Vaccination Market Forecast by Product
12.2.1 Global Influenza Vaccination Sales Forecast by Product 2019-2025
12.2.2 Global Influenza Vaccination Revenue Forecast by Product 2019-2025
12.3 Influenza Vaccination Market Forecast by End User
12.4 North America Influenza Vaccination Forecast
12.5 Europe Influenza Vaccination Forecast
12.6 Asia Pacific Influenza Vaccination Forecast
12.7 Central & South America Influenza Vaccination Forecast
12.8 Middle East and Africa Influenza Vaccination Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Vaccination Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Influenza Vaccination Product Picture
Table Influenza Vaccination Market Segments
Table Key Manufacturers Influenza Vaccination Covered
Table Global Influenza Vaccination Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Influenza Vaccination Sales Market Share by Product 2014-2025
Figure Egg Based Product Picture
Table Major Manufacturers of Egg Based
Figure Cell Culture Product Picture
Table Major Manufacturers of Cell Culture
Figure Recombinant Product Picture
Table Major Manufacturers of Recombinant
Table Global Influenza Vaccination Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Research Organizations
Figure Influenza Vaccination Report Years Considered
Figure Global Influenza Vaccination Market Size 2014-2025 (Million US$)
Figure Global Influenza Vaccination Sales 2014-2025 (K Units)
Table Global Influenza Vaccination Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Influenza Vaccination Sales by Regions 2014-2019 (K Units)
Table Global Influenza Vaccination Sales Market Share by Regions 2014-2019
Figure Global Influenza Vaccination Sales Market Share by Regions 2014-2019
Figure 2018 Global Influenza Vaccination Sales Market Share by Regions
Table Global Influenza Vaccination Revenue by Regions 2014-2019 (Million US$)
Table Global Influenza Vaccination Revenue Market Share by Regions 2014-2019
Figure Global Influenza Vaccination Revenue Market Share by Regions 2014-2019
Figure 2018 Global Influenza Vaccination Revenue Market Share by Regions
Table Global Influenza Vaccination Sales by Manufacturers (2014-2019) (K Units)
Table Global Influenza Vaccination Sales Share by Manufacturers (2014-2019)
Figure Global Influenza Vaccination Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Influenza Vaccination Revenue by Manufacturers (2014-2019) (Million USD)
Table Influenza Vaccination Revenue Share by Manufacturers (2014-2019)
Figure Influenza Vaccination Value Share by Manufacturers in 2018
Table Key Manufacturers Influenza Vaccination Price (2014-2019) (USD/Unit)
Table Influenza Vaccination Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Influenza Vaccination Product Type
Table Date of International Manufacturers Enter into Influenza Vaccination Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Influenza Vaccination Sales by Product (2014-2019) (K Units)
Table Global Influenza Vaccination Sales Share by Product (2014-2019)
Figure Global Influenza Vaccination Sales Market Share by Product (2014-2019)
Figure Global Influenza Vaccination Sales Market Share by Product in 2018
Table Global Influenza Vaccination Revenue by Product (2014-2019) (Million US$)
Table Global Influenza Vaccination Revenue Share by Product (2014-2019)
Figure Global Influenza Vaccination Revenue Market Share by Product (2014-2019)
Figure Global Influenza Vaccination Revenue Market Share by Product in 2018
Table Influenza Vaccination Price by Product 2014-2019 (USD/Unit)
Table Global Influenza Vaccination Sales by End User (2014-2019) (K Units)
Table Global Influenza Vaccination Sales Share by End User (2014-2019)
Figure Global Sales Influenza Vaccination Market Share by End User (2014-2019)
Figure Global Sales Influenza Vaccination Market Share by End User in 2018
Figure North America Influenza Vaccination Sales Growth Rate 2014-2019 (K Units)
Figure North America Influenza Vaccination Revenue Growth Rate 2014-2019 (Million US$)
Table North America Influenza Vaccination Sales by Countries (2014-2019) (K Units)
Table North America Influenza Vaccination Sales Market Share by Countries (2014-2019)
Figure 2018 North America Influenza Vaccination Sales Market Share by Countries
Table North America Influenza Vaccination Revenue by Countries (2014-2019) (Million US$)
Table North America Influenza Vaccination Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Influenza Vaccination Revenue Market Share by Countries
Figure United States Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure United States Influenza Vaccination Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Canada Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Table North America Influenza Vaccination Sales by Product (2014-2019) (K Units)
Table North America Influenza Vaccination Sales Market Share by Product (2014-2019)
Figure 2018 North America Influenza Vaccination Market Share by Product
Table North America Influenza Vaccination Sales by End User (2014-2019) (K Units)
Table North America Influenza Vaccination Sales Market Share by End User (2014-2019)
Figure 2018 North America Influenza Vaccination Market Share by End User
Figure Europe Influenza Vaccination Sales Growth Rate 2014-2019 (K Units)
Figure Europe Influenza Vaccination Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Influenza Vaccination Sales by Countries (2014-2019) (K Units)
Table Europe Influenza Vaccination Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Influenza Vaccination Sales Market Share by Countries
Table Europe Influenza Vaccination Revenue by Countries (2014-2019) (Million US$)
Table Europe Influenza Vaccination Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Influenza Vaccination Revenue Market Share by Countries
Figure Germany Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Germany Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure France Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure France Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure UK Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Italy Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Russia Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Influenza Vaccination Sales by Product (2014-2019) (K Units)
Table Europe Influenza Vaccination Sales Market Share by Product (2014-2019)
Figure 2018 Europe Influenza Vaccination Market Share by Product
Table Europe Influenza Vaccination Sales by End User (2014-2019) (K Units)
Table Europe Influenza Vaccination Sales Market Share by End User (2014-2019)
Figure 2018 Europe Influenza Vaccination Market Share by End User
Figure Asia Pacific Influenza Vaccination Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Influenza Vaccination Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Influenza Vaccination Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Influenza Vaccination Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Influenza Vaccination Sales Market Share by Countries
Table Asia Pacific Influenza Vaccination Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Influenza Vaccination Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Influenza Vaccination Revenue Market Share by Countries
Figure China Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure China Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Japan Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Korea Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure India Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure India Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Australia Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Influenza Vaccination Sales by Product (2014-2019) (K Units)
Table Asia Pacific Influenza Vaccination Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Influenza Vaccination Market Share by Product
Table Asia Pacific Influenza Vaccination Sales by End User (2014-2019) (K Units)
Table Asia Pacific Influenza Vaccination Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Influenza Vaccination Market Share by End User
Figure Central & South America Influenza Vaccination Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Influenza Vaccination Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Influenza Vaccination Sales by Countries (2014-2019) (K Units)
Table Central & South America Influenza Vaccination Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Influenza Vaccination Sales Market Share by Countries
Table Central & South America Influenza Vaccination Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Influenza Vaccination Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Influenza Vaccination Revenue Market Share by Countries
Figure Brazil Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Influenza Vaccination Sales by Product (2014-2019) (K Units)
Table Central & South America Influenza Vaccination Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Influenza Vaccination Market Share by Product
Table Central & South America Influenza Vaccination Sales by End User (2014-2019) (K Units)
Table Central & South America Influenza Vaccination Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Influenza Vaccination Market Share by End User
Figure Middle East and Africa Influenza Vaccination Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Influenza Vaccination Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Influenza Vaccination Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Influenza Vaccination Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Influenza Vaccination Sales Market Share by Countries
Table Middle East and Africa Influenza Vaccination Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Influenza Vaccination Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Influenza Vaccination Revenue Market Share by Countries
Figure GCC Countries Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Influenza Vaccination Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Influenza Vaccination Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Influenza Vaccination Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Influenza Vaccination Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Influenza Vaccination Market Share by Product
Table Middle East and Africa Influenza Vaccination Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Influenza Vaccination Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Influenza Vaccination Market Share by End User
Table Abbott (U.S.) Company Details
Table Abbott (U.S.) Influenza Vaccination Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott (U.S.) Recent Development
Table AstraZeneca (Europe) Company Details
Table AstraZeneca (Europe) Influenza Vaccination Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca (Europe) Recent Development
Table BioCryst Pharmaceuticals, Inc. (U.S.) Company Details
Table BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BioCryst Pharmaceuticals, Inc. (U.S.) Recent Development
Table Novartis AG (Europe) Company Details
Table Novartis AG (Europe) Influenza Vaccination Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG (Europe) Recent Development
Table DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Company Details
Table DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Recent Development
Table GlaxoSmithKline plc. (Europe) Company Details
Table GlaxoSmithKline plc. (Europe) Influenza Vaccination Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline plc. (Europe) Recent Development
Table Hualan Biological Engineering Inc (Asia Pacific) Company Details
Table Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Hualan Biological Engineering Inc (Asia Pacific) Recent Development
Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Details
Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Recent Development
Table F. Hoffmann-La Roche Ltd (Europe) Company Details
Table F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd (Europe) Recent Development
Table Sanofi (Europe) Company Details
Table Sanofi (Europe) Influenza Vaccination Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi (Europe) Recent Development
Table Global Influenza Vaccination Sales Forecast by Regions 2019-2025 (K Units)
Table Global Influenza Vaccination Sales Market Share Forecast by Regions 2019-2025
Table Global Influenza Vaccination Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Influenza Vaccination Revenue Market Share Forecast by Regions 2019-2025
Table Global Influenza Vaccination Sales Forecast by Product 2019-2025 (K Units)
Table Global Influenza Vaccination Sales Market Share Forecast by Product 2019-2025
Table Global Influenza Vaccination Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Influenza Vaccination Revenue Market Share Forecast by Product 2019-2025
Table Global Influenza Vaccination Sales Forecast by End User 2019-2025 (K Units)
Table Global Influenza Vaccination Sales Market Share Forecast by End User 2019-2025
Figure North America Influenza Vaccination Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Influenza Vaccination Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Influenza Vaccination Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Influenza Vaccination Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Influenza Vaccination Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Influenza Vaccination Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Influenza Vaccination Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Influenza Vaccination Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Influenza Vaccination Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Influenza Vaccination Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Influenza Vaccination Value Chain
Table Influenza Vaccination Customers List
Table Influenza Vaccination Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs